关注
Joo Dong Park
Joo Dong Park
在 skku.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Cationic nanoparticle-mediated activation of natural killer cells for effective cancer immunotherapy
KS Kim, JH Han, SH Choi, HY Jung, JD Park, HJ An, SE Kim, DH Kim, ...
ACS Applied Materials & Interfaces 12 (51), 56731-56740, 2020
582020
Functional link between miR-200a and ELK3 regulates the metastatic nature of breast cancer
HK Kim, JD Park, SH Choi, DJ Shin, S Hwang, HY Jung, KS Park
Cancers 12 (5), 1225, 2020
262020
3D-printed NIR-responsive bullets as multifunctional nanodrug platforms for image-guided local chemo-photothermal therapy
G Han, H Lee, JM Kang, JH Park, E Lee, ES Lee, S Park, Y Na, MH Kang, ...
Chemical Engineering Journal 477, 147083, 2023
112023
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
JD Park, KS Kim, SH Choi, GH Jo, JH Choi, SW Park, ES Ko, M Lee, ...
Journal for Immunotherapy of Cancer 10 (7), 2022
112022
Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy
SH Choi, HJ Kim, JD Park, ES Ko, M Lee, DK Lee, JH Choi, HJ Jang, ...
Journal for ImmunoTherapy of Cancer 10 (8), 2022
102022
Enhancing CAR‐NK Cells Against Solid Tumors Through Chemical and Genetic Fortification with DOTAP‐Functionalized Lipid Nanoparticles
HE Shin, JH Han, JD Park, M Park, J Han, MH Kang, JS Lee, CG Park, ...
Advanced Functional Materials, 2315721, 2024
92024
The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics
JD Park, HJ Jang, SH Choi, GH Jo, JH Choi, S Hwang, W Park, KS Park
Cell death discovery 9 (1), 237, 2023
52023
ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer
HY Jung, DK Lee, M Lee, SH Choi, JD Park, ES Ko, J Lee, KS Park, ...
Oncoimmunology 12 (1), 2190671, 2023
22023
ELK3-ID4 axis governs the metastatic features of triple negative breast cancer
JH Choi, JD Park, SH Choi, ES Ko, HJ Jang, KS Park
Oncology Research 32 (1), 127, 2023
22023
系统目前无法执行此操作,请稍后再试。
文章 1–9